Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold-Reference-Cited by-同舟云学术

Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold

Published:2022-03 Issue: Volume:120 Page:105631
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Hassan Abdelfattah,Badr Mohamed,Abdelhamid Dalia,Hassan Heba A.,Abourehab Mohammed A.S.,Abuo‐Rahma Gamal El‐Din A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference30 articles.

1. Global Cancer Observatory: Cancer Today https://gco.iarc.fr/, International Agency for Research on Cancer, Lyon, 2020.

2. World Health Organization Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/cancer (accessed July 1, 2021).

3. InternationalAgency for Research on Cancer. https://gco.iarc.fr/today/home (accessed July 1, 2021).

4. Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective;Modi;Med. Drug Discov.,2019

5. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma;Modi;Eur. J. Med. Chem.,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities;Pharmaceuticals;2024-08-31

2. Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy;Medicinal Chemistry Research;2024-06-27

3. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

4. Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability;Journal of Thoracic Disease;2024-02

5. Apatinib reduces liver cancer cell multidrug resistance by modulating NF-κB signaling pathway;BIOCELL;2024